Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Glioblastoma × mirdametinib × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neurofibromatosis 1 3 Neurofibromatoses 2 Neurofibroma 2 Melanoma 2 Colorectal Neoplasms 2 Breast Neoplasms 2 Vascular Malformations 1 Solid Tumor, Adult 1 Skin Diseases, Vascular 1 Primary Malignant Peripheral Nerve Sheath Tumors 1 Oligodendroglioma 1 Neurofibroma, Plexiform 1 Neurocytoma 1 Neoplasms, Neuroepithelial 1 NF1 1 Multiple Myeloma 1 Lymphatic Abnormalities 1 Lymphangioma, Cystic 1 Lymphangioma 1 Liposarcoma, Myxoid 1 Liposarcoma 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 KRAS Mutant Non-Small Cell Lung Cancer 1 Glioma 1 Glioblastoma 1 Ganglioneuroma 1 Ganglioglioma 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Astrocytoma 1

Interventions

Temozolomide 393 Radiotherapy 196 Bevacizumab 155 Radiation 77 Magnetic Resonance Spectroscopy 67 Lomustine 47 Surgical Procedures, Operative 42 Carmustine 41 pembrolizumab 39 Irinotecan 38 Nivolumab 32 Carboplatin 27 Specimen Handling 26 Radiosurgery 24 Erlotinib Hydrochloride 24 Chemotherapy, Adjuvant 23 Radiotherapy, Intensity-Modulated 22 Drug Therapy 20 Aminolevulinic Acid 20 Cyclophosphamide 19 O(6)-benzylguanine 17 sargramostim 16 Radiotherapy, Conformal 15 temsirolimus 14 Granulocyte-Macrophage Colony-Stimulating Factor 14 Everolimus 14 Vorinostat 13 Sorafenib 13 poly ICLC 12 Ipilimumab 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07521657 2026-04-13

NF118

University of Alabama at Birmingham

Phase 2 Not yet recruiting

Glioblastoma, Glioma, Neurofibromatosis 1

Data powered by HemOnc (CC BY 4.0) Colophon ⚡